{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:15:40Z","timestamp":1793301340086,"version":"4.5.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T00:00:00Z","timestamp":1629417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Hereditary alpha tryptasemia (H\u03b1T) is a recently described autosomal dominant genetic trait caused by an increased copy number of the TPSAB1 gene. It commonly leads to elevated basal serum tryptase levels, and it is associated with heterogeneous clinical manifestations. Some individuals report few to no symptoms, while others present with a spectrum of debilitating features. Most symptoms related to H\u03b1T may be explained by mast cell activation and mediator release, namely multiple allergies, anaphylaxis, and skin rash. However, the genotype-phenotype correlation has not yet been clearly understood. In particular, the characterization of the clinical spectrum lacks in children, where differential diagnosis could be challenging. Systemic mastocytosis, H\u03b1T, and mast cell activation syndrome are all associated with overlapping pathophysiology and symptoms, making the distinction between these conditions a difficult task. We herein describe two pediatric cases of H\u03b1T and their respective families at our tertiary care teaching hospital, highlighting the diagnostic workup and differential diagnosis. We also provide a brief review of the literature to underline the peculiar features of this condition in children.<\/jats:p>","DOI":"10.3389\/fped.2021.716786","type":"journal-article","created":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T14:35:07Z","timestamp":1629470107000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Case Report: Hereditary Alpha Tryptasemia in Children: A Pediatric Case Series and a Brief Overview of Literature"],"prefix":"10.3389","volume":"9","author":[{"given":"Daniele","family":"Zama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Muratore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Giannetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iria","family":"Neri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Magini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pession","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1038\/ng.3696","article-title":"Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number","volume":"48","author":"Lyons","year":"2016","journal-title":"Nat Genet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1046\/j.1365-2222.2002.01416.x","article-title":"Genetic deficiency of human mast cell alpha-tryptase","volume":"32","author":"Soto","year":"2002","journal-title":"Clin Exp Allergy."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1016\/j.jaip.2020.01.012","article-title":"Usefulness of testing for hereditary alpha tryptasemia in symptomatic patients with elevated tryptase","volume":"8","author":"Carrigan","year":"2020","journal-title":"J allergy Clin Immunol Pract."},{"key":"B4","doi-asserted-by":"publisher","first-page":"3549","DOI":"10.1016\/j.jaip.2020.05.057","article-title":"Hereditary alpha-tryptasemia: UK prevalence and variability in disease expression","volume":"8","author":"Robey","year":"2020","journal-title":"J allergy Clin Immunol Pract."},{"key":"B5","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.aller.2014.05.002","article-title":"Clinical characteristics and risk profile of patients with elevated baseline serum tryptase","volume":"42","author":"Fellinger","year":"2014","journal-title":"Allergol Immunopathol (Madr)."},{"key":"B6","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.iac.2018.04.003","article-title":"Hereditary alpha tryptasemia: genotyping and associated clinical features","volume":"38","author":"Lyons","year":"2018","journal-title":"Immunol Allergy Clin North Am."},{"key":"B7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/all.13657","article-title":"Mast cell disorders: from infancy to maturity","volume":"74","author":"Wilcock","year":"2019","journal-title":"Allergy."},{"key":"B8","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.jaci.2020.06.035","article-title":"Heritable risk for severe anaphylaxis associated with increased \u03b1-tryptase-encoding germline copy number at TPSAB1","volume":"147","author":"Lyons","year":"2020","journal-title":"J Allergy Clin Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1182\/blood.2020006157","article-title":"Hereditary \u03b1 tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis","volume":"137","author":"Greiner","year":"2021","journal-title":"Blood."},{"key":"B10","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.clim.2007.02.007","article-title":"Tryptase haplotype in mastocytosis: relationship to disease variant and diagnostic utility of total tryptase levels","volume":"123","author":"Akin","year":"2007","journal-title":"Clin Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1056\/NEJMra1409760","article-title":"mast cells, mastocytosis, and related disorders","volume":"373","author":"Theoharides","year":"2015","journal-title":"N Engl J Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1067\/mai.2002.121454","article-title":"Characterization of mast-cell tryptase-expressing peripheral blood cells as basophils","volume":"109","author":"Foster","year":"2002","journal-title":"J Allergy Clin Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1600-065X.2007.00509.x","article-title":"Mast cell tryptases and chymases in inflammation and host defense","volume":"217","author":"Caughey","year":"2007","journal-title":"Immunol Rev."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1084\/jem.20190701","article-title":"Impact of naturally forming human \u03b1\/\u03b2-tryptase heterotetramers in the pathogenesis of hereditary \u03b1-tryptasemia","volume":"216","author":"Le","year":"2019","journal-title":"J Exp Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"5667","DOI":"10.4049\/jimmunol.170.11.5667","article-title":"Tryptase precursors are preferentially and spontaneously released, whereas mature tryptase is retained by HMC-1 cells, Mono-Mac-6 cells, and human skin-derived mast cells","volume":"170","author":"Schwartz","year":"2003","journal-title":"J Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.iac.2006.05.010","article-title":"Diagnostic value of tryptase in anaphylaxis and mastocytosis","volume":"26","author":"Schwartz","year":"2006","journal-title":"Immunol Allergy Clin North Am."},{"key":"B17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s11882-019-0887-x","article-title":"Mast cell activation in the context of elevated basal serum tryptase: genetics and presentations","volume":"19","author":"Khoury","year":"2019","journal-title":"Curr Allergy Asthma Rep."},{"key":"B18","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1182\/blood.2020008466","article-title":"What your H\u03b1T says about you","volume":"137","author":"Gotlib","year":"2021","journal-title":"Blood."},{"key":"B19","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1097\/PAS.0000000000001676","article-title":"Distinct small intestine mast cell histologic changes in patients with hereditary alpha-tryptasemia and mast cell activation syndrome","volume":"45","author":"Hamilton","year":"2021","journal-title":"Am J Surg Pathol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s10875-018-0506-y","article-title":"First identification of an inherited TPSAB1 quintuplication in a patient with clonal mast cell disease","volume":"38","author":"Sabato","year":"2018","journal-title":"J Clin Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/gim.2017.136","article-title":"A common haplotype containing functional CACNA1H variants is frequently coinherited with increased TPSAB1 copy number","volume":"20","author":"Lyons","year":"2018","journal-title":"Genet Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.jaci.2019.08.023","article-title":"AAAAI Mast Cell Disorders Committee Work Group Report: mast cell activation syndrome (MCAS) diagnosis and management","volume":"144","author":"Weiler","year":"2019","journal-title":"J Allergy Clin Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.critrevonc.2014.09.001","article-title":"The genetic basis of mast cell activation disease - looking through a glass darkly","volume":"93","author":"Molderings","year":"2015","journal-title":"Crit Rev Oncol Hematol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"3914","DOI":"10.1182\/blood.V90.10.3914","article-title":"Mitogenic responses mediated through the proteinase-activated receptor-2 are induced by expressed forms of mast cell \u03b1- or \u03b2-tryptases","volume":"90","author":"Mirza","year":"1997","journal-title":"Blood."},{"key":"B25","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.4049\/jimmunol.158.5.2310","article-title":"Human mast cells activate fibroblasts: tryptase is a fibrogenic factor stimulating collagen messenger ribonucleic acid synthesis and fibroblast chemotaxis","volume":"158","author":"Gruber","year":"1997","journal-title":"J Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/(SICI)1097-4652(199911)181:2<312::AID-JCP13>3.0.CO;2-1","article-title":"Mast cell tryptase does not alter matrix metalloproteinase expression in human dermal fibroblasts: further evidence that proteolytically-active tryptase is a potent fibrogenic factor","volume":"181","author":"Zhang","year":"1999","journal-title":"J Cell Physiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1182\/blood-2016-09-731893","article-title":"Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts","volume":"129","author":"Valent","year":"2017","journal-title":"Blood."},{"key":"B29","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3390\/medicina57020124","article-title":"Mast cell activation disorders","volume":"57","author":"Giannetti","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"B30","doi-asserted-by":"publisher","first-page":"ajh.25371","DOI":"10.1002\/ajh.25371","article-title":"Systemic mastocytosis in adults: 2019 update on diagnosis, risk stratification and management","volume":"94","author":"Pardanani","year":"2018","journal-title":"Am J Hematol"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.716786\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T19:15:12Z","timestamp":1673118912000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2021.716786\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,20]]},"references-count":30,"alternative-id":["10.3389\/fped.2021.716786"],"URL":"https:\/\/doi.org\/10.3389\/fped.2021.716786","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,20]]},"article-number":"716786"}}